This type of Immuno-PLA is therefore highly suited to reveal the different activation states of the canonical NF-κB pathway in heterogeneous tumor cell lines or co-cultures of tumor cells with stroma or immune cells. The gene discussed is NFKB1; the disease is neoplasm.